Vicus Capital’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
MG
WBG
PVH
HF
Vicus Capital's XPH Position: Q3 2015 in Review
Vicus Capital sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2015, closing a stake of 103,790 shares — an estimated $6.47M sold.
Vicus Capital first reported a position in XPH in Q4 2014 and held it in 3 quarters. The position peaked at $6.47M in Q2 2015. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2015.
- Vicus Capital reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
- Vicus Capital sold 103,790 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2015, an estimated $6.47M.
- Vicus Capital first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2014 and held it in 3 quarters.
- Vicus Capital's State Street SPDR S&P Pharmaceuticals ETF position peaked at $6.47M in Q2 2015.
- 77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2015.
Based on Vicus Capital's 13F filing for Q3 2015, filed 15 Oct 2015.